Access to this content is restricted
Learning objectives
- To provide an overview of validated methods for the detection of RET gene rearrangements and how to apply them rationally in the clinical practice
- To provide an update on clinical development of RET inhibitors (both unspecified, ie vandetanib, cabozantinib, etc, and specified) across broad range of tumours
- To elaborate how to understand, assess and overcome the mechanisms of resistance to RET inhibitors
The programme is designed to offer an overview of research activities in this area and review the current status and future prospect of testing and targeting various tumours with RET alterations.
